Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On the familial predisposition to favism.

Literature DB >> 5944419

On the familial predisposition to favism.

G Stamatoyannopoulos, G R Fraser, A C Motulsky, P Fessas, A Akrivakis, T Papayannopoulou.

Abstract

Entities: Disease

Mesh：

Year: 1966 PMID： 5944419 PMCID： PMC1706088

Source DB: PubMed Journal: Am J Hum Genet ISSN： 0002-9297 Impact factor: 11.025

× No keyword cloud information.

11 in total

1. MILD GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN GREEK MALES.

Authors: G STAMATOYANNOPOULOS; A PANAYOTOPOULOS; T PAPAYANNOPOULOU
Journal: Lancet Date: 1964-10-31 Impact factor: 79.321

2. GLUCOSE-6-PHOSPHATE DEHYDROGENASE, COLOUR VISION AND XG BLOOD GROUPS IN GREECE: LINKAGE AND POPULATION DATA.

Authors: G R FRASER; B DEFARANAS; C A KATTAMIS; R R RACE; R SANGER; G STAMATOYANNOPOULOS
Journal: Ann Hum Genet Date: 1964-06 Impact factor: 1.670

3. THALASSAEMIA, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, SICKLING, AND MALARIAL ENDEMICITY IN GREECE: A STUDY OF FIVE AREAS.

Authors: G STAMATOYANNOPOULOS; P FESSAS
Journal: Br Med J Date: 1964-04-04

4. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.

Authors: A R TARLOV; G J BREWER; P E CARSON; A S ALVING
Journal: Arch Intern Med Date: 1962-02

5. Neonatal jaundice in glucose-6-phosphate-dehydrogenase-deficient infants.

Authors: P FESSAS; S A DOXIADIS; T VALAES
Journal: Br Med J Date: 1962-11-24

6. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.

Authors: R W KELLERMEYER; A R TARLOV; G J BREWER; P E CARSON; A S ALVING
Journal: JAMA Date: 1962-05-05 Impact factor: 56.272

7. Studies on erthrocytes in cases with past history of favism and drug-induced acute hemolytic anemia.

Authors: A SZEINBERG; C SHEBA; N HIRSHORN; E BODONYI
Journal: Blood Date: 1957-07 Impact factor: 22.113

8. [The bio-enzymatic individuality of the fabic erythrocytes; some biochemical & enzymatic anomalies of erythrocytes in patients affected with favism & members of their family].

Authors: P LARIZZA; P BRUNETTI; F GRIGNANI; S VENTURA
Journal: Haematologica Date: 1958 Impact factor: 9.941

9. [Effects of the administration of fava beans and primaquine on glucose-6-phosphate dehy-drogenase-deficient erythrocytes labeled with Cr-51].

Authors: F PANIZON; C VULLO
Journal: Haematologica Date: 1962 Impact factor: 9.941

10. Metabolic effects of pyrimidines derived from fava bean glycosides on human erythrocytes deficient in glucose-6-phosphate dehydrogenase.

Authors: J Mager; G Glaser; A Razin; G Izak; S Bien; M Noam
Journal: Biochem Biophys Res Commun Date: 1965-07-12 Impact factor: 3.575

13 in total

On the familial predisposition to favism.

1. MILD GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN GREEK MALES.

2. GLUCOSE-6-PHOSPHATE DEHYDROGENASE, COLOUR VISION AND XG BLOOD GROUPS IN GREECE: LINKAGE AND POPULATION DATA.

3. THALASSAEMIA, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, SICKLING, AND MALARIAL ENDEMICITY IN GREECE: A STUDY OF FIVE AREAS.

4. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.

5. Neonatal jaundice in glucose-6-phosphate-dehydrogenase-deficient infants.

6. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.

7. Studies on erthrocytes in cases with past history of favism and drug-induced acute hemolytic anemia.

8. [The bio-enzymatic individuality of the fabic erythrocytes; some biochemical & enzymatic anomalies of erythrocytes in patients affected with favism & members of their family].

9. [Effects of the administration of fava beans and primaquine on glucose-6-phosphate dehy-drogenase-deficient erythrocytes labeled with Cr-51].

10. Metabolic effects of pyrimidines derived from fava bean glycosides on human erythrocytes deficient in glucose-6-phosphate dehydrogenase.

1. Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases.

2. Favism: current problems and investigations.

3. On the pathogenesis of favism.

4. G6PD deficiency and favism in the island of Rhodes (Greece).

5. Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria.

6. Favism: clinical and biochemical data.

7. Defective molecular variants of glucose-6-phosphate dehydrogenase and methaemoglobin reductase.

8. Genetic diversity of the "Mediterranean" glucose-6-phosphate dehydrogenase deficiency phenotype.

9. Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.

10. Glucose-6-phosphate dehydrogenase deficiency and chronic haemolysis in an English family.